This trial is active, not recruiting.

Condition chronic obstructive pulmonary disease
Sponsor China-Japan Friendship Hospital
Collaborator Peking University
Start date January 2016
End date December 2016
Trial size 7600 participants
Trial identifier NCT02657525, 2015-88


The purpose of this study is to investigate the demographic characteristics, clinical features, diagnoses and treatments of AECOPD hospitalized patients in China, and disease prognosis and its economic burden.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective

Primary Outcomes

In-hospital mortality
time frame: 12 months
time frame: 12 months

Secondary Outcomes

All-cause and cause-specific mortality
time frame: 3 years
Recurrence of acute exacerbation of COPD
time frame: 3 years
Lung function and quality of life assessment
time frame: 3 years
Healthcare costs
time frame: 12 months

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: ≥18 years of age; hospitalized patients with main diagnosis as AECOPD. Exclusion Criteria: Patients diagnosed as active pulmonary tuberculosis, or acute left heart failure; Patients participating in clinical trials or intervention studies of drugs.

Additional Information

Official title Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by China-Japan Friendship Hospital.